β-Adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (16) , 2615-2622
- https://doi.org/10.1016/0006-2952(84)90634-8
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Mammalian platelet adrenoceptorsBritish Journal of Pharmacology, 1984
- Platelet β‐adrenoceptorsBritish Journal of Pharmacology, 1983
- Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosityThrombosis Research, 1982
- PLATELET AGGREGATION AND BETA-BLOCKERSThe Lancet, 1982
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981
- Effects of propranolol and pindolol on platelet aggregation and serotonin releaseLife Sciences, 1977
- Effect of propranolol on platelet functionBlood, 1977
- Potentiation by α and Inhibition by β-Adrenergic Stimulations of Rat Platelet AggregationThrombosis and Haemostasis, 1977
- Inhibition by antiarrhythmic and ?-sympatholytic drugs of serotonin uptake by human platelets: Experimentsin vitro andin vivoEuropean Journal of Clinical Pharmacology, 1973
- Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazineEuropean Journal of Pharmacology, 1970